Active-duty US soldiers to receive psychedelic drugs for PTSD next year
🤖AI Özeti
Active-duty US soldiers suffering from PTSD are set to receive MDMA-assisted therapy next year, as part of two studies funded by the Department of Defense. This innovative approach aims to help service personnel process trauma more effectively. The initiative reflects a significant shift in the military's approach to mental health treatment, particularly as the stigma around psychedelic drugs begins to diminish.
💡AI Analizi
📚Bağlam ve Tarihsel Perspektif
The U.S. military has long grappled with high rates of PTSD among service members, particularly following extended deployments in conflict zones. Traditional treatments have often fallen short, leading to a search for more effective solutions. The growing body of research supporting the therapeutic potential of psychedelics has prompted this new initiative, which could significantly alter the landscape of mental health care in the armed forces.
This article reflects the views and opinions of the author and does not necessarily represent the views of The Guardian.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.